Susan Rinkunas
co-founder of Autonomy News
Susan Rinkunas is an independent journalist and co-founder of Autonomy News. Her work has appeared in Jezebel, The New Republic, The Guardian, Slate, The Nation and more.
Susan Rinkunas
co-founder of Autonomy News
Susan Rinkunas is an independent journalist and co-founder of Autonomy News. Her work has appeared in Jezebel, The New Republic, The Guardian, Slate, The Nation and more.
Latest from
Susan Rinkunas
A safety review of mifepristone is unnecessary. More than 100 studies have found that it’s a safe and effective way to end a pregnancy.
His official plan, laid out Thursday, should be a wake-up call for anyone who still believed he would make IVF free.
This administration has already shown that it will ignore scientific evidence to advance its own narratives.
Conservative groups who lobbied against the sale of the medication are pledging to target retailers that already dispense the drug, which would be a blow to abortion access.
A year ago, the president claimed that if he won, his administration would be “paying for that treatment.” Guess what happened next?
What the senator claimed was a difficult decision was just a case of backroom deals and abandoned principles.
There are many other ways the administration and its allies can still restrict mifepristone access.
As the second Trump administration enacts more of its policy goals, abortion opponents are trying to starve abortion providers of any federal funding.
It leaves the law unchanged, but seeks to create the illusion of an accomplishment that’s popular with the electorate.
As the laws’ predictable harms come to light, anti-abortion groups want us to look away.